Catalyst Pharmaceuticals (CPRX) Tax Rate (2019 - 2026)
Catalyst Pharmaceuticals' (CPRX) quarterly Tax Rate came in at 24.33% in Q1 2026, up 392.0% YoY from 4.95% in Q1 2025, and up 83.16% on a QoQ basis from 13.28% in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Tax Rate (2019 - 2026) Analysis & Trends
Catalyst Pharmaceuticals (CPRX) has 8 years of Tax Rate data on file, last reported at 24.33% in Q1 2026.
- Quarterly Tax Rate rose 392.0% year-over-year to 24.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 22.09% (down 155.0% YoY) and the FY2025 annual result came in at 21.0%, down 322.0% from the prior year.
- Tax Rate improved to 24.33% in Q1 2026, from 13.28% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 63.52% in Q4 2023 to a low of 12.53% in Q3 2022.
- A 5-year average of 24.22% and a median of 23.29% in 2024 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2023 — Tax Rate jumped 4069 bps — and 2024, when it plunged 3892 bps.
- Tracing CPRX's Tax Rate over 5 years: stood at 22.83% in 2022, then jumped by 178 bps to 63.52% in 2023, then sank by 61 bps to 24.6% in 2024, then tumbled by 46 bps to 13.28% in 2025, then jumped by 83 bps to 24.33% in 2026.
- The last three Tax Rate figures came in at 24.33% (Q1 2026), 13.28% (Q4 2025), and 25.69% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 24.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.33% |
| Mar 31, 2026 | 24.33% |
| Mar 31, 2026 | 24.33% |
| Dec 31, 2025 | 13.28% |
| Dec 31, 2025 | 13.28% |
| Dec 31, 2025 | 13.28% |
| Sep 30, 2025 | 25.69% |
| Sep 30, 2025 | 25.69% |
| Sep 30, 2025 | 25.69% |
| Jun 30, 2025 | 24.80% |
| Jun 30, 2025 | 24.80% |
| Jun 30, 2025 | 24.80% |
| Mar 31, 2025 | 20.41% |
| Mar 31, 2025 | 20.41% |
| Mar 31, 2025 | 20.41% |
| Dec 31, 2024 | 24.60% |
| Dec 31, 2024 | 24.60% |
| Dec 31, 2024 | 24.60% |
| Sep 30, 2024 | 23.29% |
| Sep 30, 2024 | 23.29% |